UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 205,301 Shares of Astera Labs, Inc. $ALAB

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 31.6% in the 2nd quarter, Holdings Channel reports. The firm owned 854,492 shares of the company’s stock after buying an additional 205,301 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Astera Labs were worth $412,737,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Eurizon Capital SGR S.p.A. acquired a new position in Astera Labs during the fourth quarter valued at approximately $18,708,000. Swedbank AB boosted its holdings in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in shares of Astera Labs during the 4th quarter worth $499,000. Revere Asset Management Inc acquired a new position in Astera Labs in the 4th quarter valued at $589,000. Finally, Banque Cantonale Vaudoise lifted its position in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock worth $766,000 after acquiring an additional 3,229 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Price Performance

NASDAQ ALAB opened at $289.47 on Monday. The stock’s 50 day simple moving average is $342.38 and its 200 day simple moving average is $250.08. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The firm has a market cap of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the firm earned $0.44 EPS. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the transaction, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 over the last 90 days. Company insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ALAB. Evercore reaffirmed an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. TD Cowen decreased their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Morgan Stanley upped their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Finally, Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $340.53.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.